61 related articles for article (PubMed ID: 26221761)
1. Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis.
Campello E; Zanetto A; Radu CM; Bulato C; Truma A; Spiezia L; Senzolo M; Garcia-Tsao G; Simioni P
Dig Liver Dis; 2021 Jul; 53(7):879-888. PubMed ID: 33431230
[TBL] [Abstract][Full Text] [Related]
2. Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals.
Artemenko EO; Obydennyi SI; Troyanova KS; Novichkova GA; Nechipurenko DY; Panteleev MA
Thromb Res; 2024 Jan; 233():119-126. PubMed ID: 38039724
[TBL] [Abstract][Full Text] [Related]
3. Shear-induced integrin signaling in platelet phosphatidylserine exposure, microvesicle release, and coagulation.
Pang A; Cui Y; Chen Y; Cheng N; Delaney MK; Gu M; Stojanovic-Terpo A; Zhu C; Du X
Blood; 2018 Aug; 132(5):533-543. PubMed ID: 29853537
[TBL] [Abstract][Full Text] [Related]
4. Shear-Mediated Platelet Microparticles Demonstrate Phenotypic Heterogeneity as to Morphology, Receptor Distribution, and Hemostatic Function.
Roka-Moiia Y; Ammann KR; Miller-Gutierrez S; Sheriff J; Bluestein D; Italiano JE; Flaumenhaft RC; Slepian MJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108551
[TBL] [Abstract][Full Text] [Related]
5. Vitronectin promotes immunothrombotic dysregulation in the venular microvasculature.
Uhl B; Haring F; Slotta-Huspenina J; Luft J; Schneewind V; Hildinger J; Wu Z; Steiger K; Smiljanov B; Batcha AMN; Keppler OT; Hellmuth JC; Lahmer T; Stock K; Weiss BG; Canis M; Stark K; Bromberger T; Moser M; Schulz C; Weichert W; Zuchtriegel G; Reichel CA
Front Immunol; 2023; 14():1078005. PubMed ID: 36845099
[TBL] [Abstract][Full Text] [Related]
6. Platelet-Released Factors: Their Role in Viral Disease and Applications for Extracellular Vesicle (EV) Therapy.
Ostermeier B; Soriano-Sarabia N; Maggirwar SB
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216433
[TBL] [Abstract][Full Text] [Related]
7. Oxidative and Fibrinolytic Mechanisms: Two Important Processes to Consider in Platelet Storage.
Garcia-Bañuelos JJ; Galicia-Moreno M; Monroy-Ramirez HC; Navarro-Partida J; Bastidas-Ramirez BE; Santos A; Armendariz-Borunda J
Turk J Haematol; 2023 Feb; 40(1):43-49. PubMed ID: 36718633
[TBL] [Abstract][Full Text] [Related]
8. Circulating platelets as liquid biopsy sources for cancer detection.
Antunes-Ferreira M; Koppers-Lalic D; Würdinger T
Mol Oncol; 2021 Jun; 15(6):1727-1743. PubMed ID: 33219615
[TBL] [Abstract][Full Text] [Related]
9. Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop.
Wu YW; Huang CC; Changou CA; Lu LS; Goubran H; Burnouf T
J Biomed Sci; 2020 Mar; 27(1):45. PubMed ID: 32200762
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effects of Ginsenoside Ro on Clot Retraction through Suppressing PI3K/Akt Signaling Pathway in Human Platelets.
Kwon HW
Prev Nutr Food Sci; 2019 Mar; 24(1):56-63. PubMed ID: 31008097
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36.
Munkonda MN; Akbari S; Landry C; Sun S; Xiao F; Turner M; Holterman CE; Nasrallah R; Hébert RL; Kennedy CRJ; Burger D
J Extracell Vesicles; 2018; 7(1):1432206. PubMed ID: 29435202
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants.
Bern MM
Clin Transl Med; 2017 Sep; 6(1):33. PubMed ID: 28933058
[TBL] [Abstract][Full Text] [Related]
13. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.
Lopez-Vilchez I; Diaz-Ricart M; White JG; Escolar G; Galan AM
Cardiovasc Res; 2009 Nov; 84(2):309-16. PubMed ID: 19541671
[TBL] [Abstract][Full Text] [Related]
14. Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures.
Pumiglia KM; Feinstein MB
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):253-60. PubMed ID: 7689831
[TBL] [Abstract][Full Text] [Related]
15. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro.
Scholz T; Zhao L; Temmler U; Bath P; Heptinstall S; Lösche W
Platelets; 2002 Nov; 13(7):401-6. PubMed ID: 12487787
[TBL] [Abstract][Full Text] [Related]
16. Internalization of tissue factor by platelets.
Escolar G; Lopez-Vilchez I; Diaz-Ricart M; White JG; Galan AM
Thromb Res; 2008; 122 Suppl 1():S37-41. PubMed ID: 18691498
[TBL] [Abstract][Full Text] [Related]
17. Immunoelectron microscopic changes of the platelet plasma membrane after activation.
Cramer E; Berger G
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):172-7. PubMed ID: 8735811
[TBL] [Abstract][Full Text] [Related]
18. Internalization of Tissue Factor-Rich Microvesicles by Platelets Occurs Independently of GPIIb-IIIa, and Involves CD36 Receptor, Serotonin Transporter and Cytoskeletal Assembly.
Lopez-Vilchez I; Diaz-Ricart M; Galan AM; Roque M; Caballo C; Molina P; White JG; Escolar G
J Cell Biochem; 2016 Feb; 117(2):448-57. PubMed ID: 26221761
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
